Definium Therapeutics, Inc.
DFTX
$22.01
$0.854.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -237.54M | -183.79M | -168.10M | -114.52M | -77.63M |
| Total Depreciation and Amortization | -- | -- | -527.00K | -527.00K | -527.00K |
| Total Amortization of Deferred Charges | -- | -- | 527.00K | 527.00K | 527.00K |
| Total Other Non-Cash Items | 75.43M | 42.80M | 40.66M | 6.55M | -9.20M |
| Change in Net Operating Assets | 17.35M | 9.44M | 13.50M | 6.41M | -5.13M |
| Cash from Operations | -144.77M | -131.56M | -113.94M | -101.56M | -91.95M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.85M | -151.61M | -186.59M | -202.00M | -162.46M |
| Cash from Investing | 52.85M | -151.61M | -186.59M | -202.00M | -162.46M |
| Total Debt Issued | 42.00M | 42.00M | 42.00M | 42.00M | 10.00M |
| Total Debt Repaid | -22.00M | -22.00M | -22.00M | -22.00M | -- |
| Issuance of Common Stock | 267.97M | 263.66M | 5.73M | 80.01M | 82.82M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.39M | -16.39M | -522.00K | -6.20M | -7.87M |
| Cash from Financing | 271.58M | 267.27M | 25.21M | 93.81M | 84.95M |
| Foreign Exchange rate Adjustments | 8.00K | -7.00K | -7.00K | 3.00K | -21.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 179.66M | -15.90M | -275.33M | -209.74M | -169.48M |